Manufacturing

Cynthia A. Challener, PhD, is a contributing editor to BioPharm International.

Articles

The evolution of cell-culture technology is driving the need for improvements in modeling solutions.

Cell-Culture Advances Test Bioreactor Performance Models

NIIMBL announced it is partnering with FDA through the University of Delaware to improve biopharmaceutical manufacturing.

NIIMBL and FDA Partner in Biopharmaceutical Manufacturing

Real-time monitoring of product- and process-related impurities remains a challenge.

Analysis of Residual Impurities in Continuous Manufacturing

Agnes Shanley is senior editor of BioPharm International.

Although downstream efficiency still lags behind upstream, engineering-driven innovation is breaking through boundaries.

Catching Up Downstream

The learning curve for process analytical technology has slowed widespread adoption. 

Moving PAT from Concept to Reality

Pharmaceutical Technology and BioPharm International will present a Keynote Session on Meeting Bioprocessing Manufacturing Capacity Demands on Wednesday, April 3, 2019, during INTERPHEX 2019 at the Javits Center in New York City.

Biologic Drug Manufacturing Capacity on the Agenda for INTERPHEX 2019 Keynote Series

Educational sessions on the INTERPHEX show floor will include a panel discussion on implementing continuous manufacturing.

INTERPHEX 2019 Keynote Series Presents Panel Discussion on OSD Continuous Manufacturing

3D printing offers a new design freedom for bio/pharmaceutical manufacturing: whether for “printing” a solid-dosage drug or for creating a piece of equipment for bio/pharmaceutical laboratories or manufacturing facilities. 

INTERPHEX 2019 Keynote Series Presents Session on 3D Printing in Pharma

Editor of Pharmaceutical Technology Europe

A look at the Univercells' NevoLine bio manufacturing platform, which incorporates principles of automated and continuous bioprocessing.

Continuous Bioprocessing of Vaccines

NJII and Pall collaborate to address biomanufacturing technology and workforce development challenges.

Manufacturing, Continuous Biologics Processing